Clinical Trial

Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.

Study acronym: GLOBE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.
Trial Details
NCT Number NCT07229027
Lead Sponsor Medialis Ltd.
Conditions Overweight (BMI > 25), Obesity & Overweight
Enrollment 500 participants
Start Date 2025-11-01
Primary Completion 2026-07 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-11-14